An update on a systematic review of the use of geriatric assessment for older adults in oncology

Annals of Oncology

Volumn 25, Issue 2, 2014, Pages 307-315

  Puts, M T E ^a   Santos, B ^a   Hardt, J ^a   Monette, J ^b   Girre, V ^c   Atenafu, E G ^d   Springall, E ^a   Alibhai, S M H ^e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Centre Hospitalier Departemental   (France)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cancer treatment; Comprehensive geriatric assessment; Frail elderly; Geriatric oncology; Newly diagnosed cancer; Systematic review

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; CANCER PATIENT; CANCER THERAPY; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; DAILY LIFE ACTIVITY; GERIATRIC ASSESSMENT; GERIATRIC CARE; GERIATRIC PATIENT; HEALTH CARE QUALITY; HUMAN; META ANALYSIS; MORTALITY; NEOPLASM; ONCOLOGY; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTIVE VALIDITY; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SYSTEMATIC REVIEW (TOPIC); UNSPECIFIED SIDE EFFECT; CROSS-SECTIONAL STUDY; NEOPLASMS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AGED; CROSS-SECTIONAL STUDIES; GERIATRIC ASSESSMENT; HUMANS; NEOPLASMS; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84893430381     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt386     Document Type: Review

References (60)

1. Smith BD, Smith GL, Hurria A et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009; 27: 2758-2765.
2. Mangin D, Heath I, Jamoulle M. Beyond diagnosis: rising to the multimorbidity challenge. BMJ 2012; 344: e3526.
3. Ritchie CS, Kvale E, Fisch MJ. Multimorbidity: an issue of growing importance for oncologists. J Oncol Pract 2011; 7: 371-374.
4. Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition-multimorbidity. JAMA 2012; 307: 2493-2494.
5. Extermann M, Aapro M, Bernabei R et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005; 55: 241-252.
6. Balducci L, Yates J. General guidelines for the management of older patients with cancer. Oncology (Williston Park) 2000; 14: 221-227.
7. Hurria A, Browner IS, Cohen HJ et al. Senior adult oncology: clinical practice guidelines in oncology. J Natl Compr Cancer Netw 2012;10(2): 162-209.
8. Pallis AG, Ring A, Fortpied C et al. EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors. Ann Oncol 2011; 22: 1922-1926.
9. Pallis AG, Fortpied C, Wedding U et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 2010; 46: 1502-1513.
10. Puts MT, Hardt J, Monette J et al. Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 2012; 104: 1134-1164.
11. Hamaker ME, Jonker JM, de Rooij SE et al. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 2012; 13: e437-e444.
12. Bellera CA, Rainfray M, Mathoulin-Pelissier S et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 2012; 23: 2166-2172.
13. Extermann M, Boler I, Reich RR et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012; 118: 3377-3386.
14. Girones R, Torregrosa D, Maestu I et al. Comprehensive Geriatric Assessment (CGA) of elderly lung cancer patients: a single-center experience. J Geriatr Oncol 2012; 3(2), 98-103.
15. Girones R, Torregrosa D, Gomez-Codina J et al. Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians. Clin Transl Oncol 2012; 14: 183-189.
16. Kristjansson SR, Ronning B, Hurria A et al. A comparison of two pre-operative frailty measures in older surgical cancer patients. J Geriatr Oncol 2012; 3(1): 1-7.
17. Winkelmann N, Petersen I, Kiehntopf M et al. Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma. J Cancer Res Clin Oncol 2011; 137: 733-738.
18. Horgan AM, Leighl NB, Coate L et al. Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol 2012; 35: 322-328.
19. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1-34.
20. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8: 336-341.
21. Aliamus V, Adam C, Druet-Cabanac M et al. [Geriatric assessment contribution to treatment decision-making in thoracic oncology]. Rev Mal Respir 2011; 28: 1124-1130.
22. Chaufour-Andre C, Bajard A, Fingal C et al. Nutritional impacts of cancer surgery in the elderly. Prospective and descriptive study. Nutr Clin Metabol 2011; 25(1): 5-13.
23. Corsetti MT, Salvi F, Perticone S et al. Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C. Leuk Res 2011; 35: 991-997.
24. Fonck M, Brunet R, Becouarn Y et al. Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: a first-line phase II study. Clin Res Hepatol Gastroenterol 2011; 35: 823-830.
25. Hamaker ME, Buurman BM, van Munster BC et al. The value of a comprehensive geriatric assessment for patient care in acutely hospitalized older patients with cancer. Oncologist 2011; 16: 1403-1412.
26. Hurria A, Togawa K, Mohile SG et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011; 29: 3457-3465.
27. LeCaer H, Greillier L, Corre R et al. A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study). Lung Cancer 2012; 77: 97-103.
28. LeCaer H, Barlesi F, Corre R et al. A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study). Br J Cancer 2011; 105: 1123-1130.
29. Owusu C, Koroukian SM, Schluchter M et al. Screening older cancer patients for a Comprehensive Geriatric Assessment: a comparison of three instruments. J Geriatr Oncol 2011; 2: 121-129.
30. Soubeyran P, Khaled H, MacKenzie M et al. Diffuse large B-cell and peripheral Tcell non-Hodgkin's lymphoma in the frail elderly. A phase II EORTC trial with a progressive and cautious treatment emphasizing geriatric assessment. J Geriatr Oncol 2011; 2(1): 36-44.
31. Valero S, Migeot V, Bouche G et al. Who needs a comprehensive geriatric assessment? A French Onco-Geriatric Screening tool (OGS). J Geriatr Oncol 2011; 2(2): 130-136.
32. Spina M, Balzarotti M, Uziel L et al. Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. Oncologist 2012; 17: 838-846.
33. Luciani A, Jacobsen PB, Extermann M et al. The impact of fatigue and anemia on functional status in older cancer patients treated with chemotherapy. J Geriatr Oncol 2012; 3(3): 182-188.
34. Olivieri A, Gini G, Bocci C et al. Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA. Oncologist 2012; 17(5): 663-672.
35. Merli F, Luminari S, Rossi G et al. Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi. Leuk Lymphoma 2012; 53: 581-588.
36. Valentiny C, Kemmler G, Stauder R. Age, sex and gender impact multidimensional geriatric assessment in elderly cancer patients. J Geriatr Oncol 2012; 3(1): 17-23.
37. Clough-Gorr KM, Thwin SS, Stuck AE et al. Examining five-and ten-year survival in older women with breast cancer using cancer-specific geriatric assessment. Eur J Cancer 2012; 48: 805-812.
38. Kanesvaran R, Li H, Koo KN et al. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol 2011; 29: 3620-3627.
39. Pottel L, Boterberg T, Pottel H et al. Determination of an adequate screening tool for identification of vulnerable elderly head and neck cancer patients treated with radio(chemo)therapy. J Geriatr Oncol 2012; 3(1): 24-32.
40. Caillet P, Canoui-Poitrine F, Vouriot J et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 2011; 29: 3636-3642.
41. Biesma B, Wymenga AN, Vincent A et al. Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study. Ann Oncol 2011; 22: 1520-1527.
42. Courtney-Brooks M, Tellawi AR, Scalici J et al. Frailty: an outcome predictor for elderly gynecologic oncology patients. Gynecol Oncol 2012; 126: 20-24.
43. Klepin HD, Geiger AM, Tooze JA et al. The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia. J Am Geriatr Soc 2011; 59: 1837-1846.
44. Lazarovici C, Khodabakhshi R, Leignel D et al. Factors leading oncologists to refer elderly cancer patients for geriatric assessment. J Geriatr Oncol 2011; 2(3): 194-199.
45. Robinson TN, Wu DS, Stiegmann GV et al. Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults. Am J Surg 2011; 202: 511-514.
46. Freyer G, Campone M, Peron J et al. Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study. Crit Rev Oncol Hematol 2011; 80: 466-473.
47. Droz J-P, Cenciu B, Lopoh A et al. Cancer in the elderly in an equatorial area: French Guiana. Aging Health 2012; 8(3): 293-300.
48. Hurria A, Cirrincione CT, Muss HB et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 2011; 29: 1290-1296.
49. Girre V, Falcou MC, Gisselbrecht M et al. Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? J Gerontol A Biol Sci Med Sci 2008; 63: 724-730.
50. Chaibi P, Magne N, Breton S et al. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol 2011; 79: 302-307.
51. Aparicio T, Girard L, Bouarioua N et al. A mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot study. Crit Rev Oncol Hematol 2011; 77: 63-69.
52. Barthelemy P, Heitz D, Mathelin C et al. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals. Crit Rev Oncol Hematol 2011; 79: 196-204.
53. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-M156.
54. Extermann M, Chen H, Cantor AB et al. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer 2002; 38: 1466-1473.
55. Extermann M, Bonetti M, Sledge GW et al. MAX2-a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer 2004; 40: 1193-1198.
56. Wedding U, Pientka L, Hoffken K. Quality-of-life in elderly patients with cancer: a short review. Eur J Cancer 2007; 43: 2203-2210.
57. Extermann M, Albrand G, Chen H et al. Are older French patients as willing as older American patients to undertake chemotherapy?. J Clin Oncol 2003; 21: 3214-3219.
58. Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007; 25: 1824-1831.
59. Kenis C, Bron D, Libert Y et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol 2013; 24: 1306-1312.
60. Extermann M, Aapro M, Audisio R et al. on behalf of the International Society of Geriatric Oncology (SIOG). Main priorities for the development of geriatric oncology: A worldwide expert perspective. J Geriatr Oncol 2011; 2: 270-273.